#Anatomic Pathology Market Industry

[marketprofessional]

Tissue Diagnostics Market Size, Share & Growth by 2033

Tissue Diagnostics Market Overview The Global Tissue Diagnostics Market has seen continuous development in the past couple of years and is anticipated to grow much further during the forecast period. The exploration introduces a total evaluation of the Tissue Diagnostics Market and contains Future patterns, Current Growth Factors, mindful sentiments, certainties, chronicled information, and factually bolstered and industry-approved market information.

According to Straits Research, the global Tissue Diagnostics market size was valued at USD 5185.23 Million in 2022. It is projected to reach from USD XX Million in 2023 to USD 9375.02 Million by 2031, growing at a CAGR of 6.8% during the forecast period (2023–2031).

After identifying promising candidates, they undergo extensive testing and optimization to enhance their effectiveness, safety, and pharmacokinetic properties. This entire process of Tissue Diagnostics Market may take several years and necessitates collaboration between scientists from diverse fields such as chemistry, biology, and pharmacology. Irrespective of the challenges encountered during Tissue Diagnostics Market, it has the potential to revolutionize lives by providing new treatments for various diseases.

Request Sample Report of Global Tissue Diagnostics Market @ https://straitsresearch.com/report/tissue-diagnostics-market/request-sample

Competitive Analysis The report contains an in-depth analysis of the vendor’s profile, including financial health, business units, key business priorities, SWOT, strategies, and views.

Abbott Laboratories F. Hoffmann-La Roche Ltd Siemens Healthineers bioMerieux Bio SB DiaGenic Enzo Life Sciences, Inc Vitro Sa (Master Diagnóstica) Tissuegnostics Gmbh Abcam Plc Sakura Finetek Japan Co., Ltd Cell Signaling Technology, Inc The vendors have been identified based on the portfolio, geographical presence, marketing & distribution channels, revenue generation, and significant R&D investments.

Request Sample Report of Global Tissue Diagnostics Market @ https://straitsresearch.com/report/tissue-diagnostics-market/request-sample

Vendors across different verticals are planning for high investments in this market, and as a result, the market is expected to grow at an impressive rate in the upcoming years. The key players are adopting various organic and inorganic growth strategies such as mergers & acquisitions, collaboration & partnerships, joint ventures, and a few other strategies to be in a strong position in the global market.

Market Segmentation Analysis The report provides a wide-ranging evaluation of the market, providing in-depth qualitative insights, historical data, and supportable projections along with the assumptions about the Tissue Diagnostics Market size. The projections featured in the report have been derived using proven research methodologies and assumptions based on the vendor’s portfolio, blogs, white papers, and vendor presentations. Thus, the research report represents every side of the Tissue Diagnostics Market and is segmented on the basis of regional markets, offerings, applications, and end-users.

By Technology IHC {Instruments [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other products], Consumables [Reagents, Antibodies, Kits]} In-Situ Hybridization {Instruments, Consumables, Software} Primary and Special Staining Digital Pathology and Workflow {Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage and Communication} Anatomic Pathology {Instruments [Microtomes and Cryostat microtomes, Tissue processors, Automatic strainers, Other products], Consumables [Reagents and Antibodies, Probes and Kits, Others]} By Applications Breast Cancer Prostate Cancer Gastric Cancer Non-Small Cell Lung Cancer Other Cancers By End-User Hospitals Research Laboratories Pharmaceutical Organizations Contract Research Organizations (CROs) Access Detailed Segmentation @ https://straitsresearch.com/report/tissue-diagnostics-market/segmentation

Regional Analysis for Tissue Diagnostics Market The regional analysis offers a comprehensive view of the Tissue Diagnostics Market sales and growth across global and country-level markets. It provides volume and market size data by region, with insights into growth trends in countries like the United States, Canada, Germany, France, China, Japan, and more. The analysis also covers major regions such as North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Benefits Tissue Diagnostics Market Industry companies to ensure business continuity with powerful protection by constantly checking the report and representing attractive growth opportunities for the companies. Tissue Diagnostics Market handles all the needs of the operators by allowing them to improve their services and concentrate on their core business. Tissue Diagnostics Market Research aims to increase business agility and reduce operational and capital expenditure with improved technology rollouts and capacity planning. The report discusses service types and regions related to this Tissue Diagnostics Market. Further, the report provides details about the major challenges affecting the market growth.

Buy Now: https://straitsresearch.com/buy-now/tissue-diagnostics-market

Other Features of the Report: Provides a thorough analysis of the key strategies with a focus on the corporate structure, R&D methods, localization strategies, production capabilities, sales, and performance in various companies. Provides valuable insights into the product portfolio, including product planning, development, and positioning. Thanks for reading this article; you can also get individual chapter-wise sections or region-wise report versions like North America, Europe, or Asia.

About Us: By Technology IHC {Instruments [Slide Staining Systems, Tissue Microarrays, Tissue Processing Systems, Slide Scanners, Other products], Consumables [Reagents, Antibodies, Kits]} In-Situ Hybridization {Instruments, Consumables, Software} Primary and Special Staining Digital Pathology and Workflow {Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage and Communication} Anatomic Pathology {Instruments [Microtomes and Cryostat microtomes, Tissue processors, Automatic strainers, Other products], Consumables [Reagents and Antibodies, Probes and Kits, Others]} By Applications Breast Cancer Prostate Cancer Gastric Cancer Non-Small Cell Lung Cancer Other Cancers By End-User Hospitals Research Laboratories Pharmaceutical Organizations Contract Research Organizations (CROs) > StraitsResearch.com is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.

Contact Us: Email: sales@straitsresearch.com Website: https://straitsresearch.com/

[health-views-updates]

Medical Display Market Case Studies: Learning from Industry Leaders

The global medical display market revenue is on a steady growth path, with its value estimated at USD 2.2 billion in 2023 and projected to reach USD 3.27 billion by 2031. This represents a compound annual growth rate (CAGR) of 5.1% over the forecast period from 2024 to 2031. The market expansion is fueled by advancements in medical imaging technologies, growing healthcare infrastructure, and increasing demand for precision diagnostics and treatment.

Medical displays are critical components in healthcare settings, providing high-resolution images essential for diagnostics, surgical procedures, and various medical applications. These specialized displays are used in radiology, surgery, pathology, and other disciplines that require accurate visualization of medical images. The market includes a range of displays, from those used in small clinics to sophisticated systems in major hospitals and research facilities.

Key Growth Drivers

Rising Demand for High-Resolution Imaging: One of the primary drivers of the medical display market is the increasing demand for high-resolution imaging in healthcare. With advances in diagnostic technologies such as magnetic resonance imaging (MRI), computed tomography (CT) scans, and digital pathology, there is a growing need for displays that can accurately present detailed medical images. Medical professionals rely on these displays to make informed decisions, improving diagnostic accuracy and patient outcomes.

Growing Adoption of Minimally Invasive Surgeries: The growing trend toward minimally invasive surgeries (MIS) is also contributing to market growth. These procedures rely heavily on real-time, high-quality visualizations provided by medical displays, ensuring precision and safety during operations. As more healthcare facilities adopt MIS techniques, the demand for advanced surgical displays continues to rise.

Technological Advancements in Display Technology: Advances in display technologies, including organic light-emitting diodes (OLEDs), 4K/8K resolution, and 3D displays, are enhancing the capabilities of medical imaging systems. These innovations allow for better visualization of anatomical details, color accuracy, and reduced eye strain for medical professionals, which are essential in fields like radiology and surgery.

Expansion of Telemedicine and Remote Diagnostics: The surge in telemedicine and remote diagnostics has further boosted demand for high-performance medical displays. As healthcare providers increasingly rely on virtual consultations and remote monitoring, the need for displays that provide accurate image reproduction has become critical. Medical-grade displays ensure that remote diagnostics are as reliable as in-person assessments.

Get Free Sample Report: https://www.snsinsider.com/sample-request/1779

Challenges and Opportunities

Despite its steady growth, the medical display market faces certain challenges. The high cost of advanced medical displays, along with the need for regular maintenance and calibration, can be barriers for smaller healthcare facilities. Additionally, the rapid pace of technological advancements requires continuous upgrades to keep up with new standards, which can be costly for hospitals and clinics.

However, opportunities are emerging through technological innovations such as AI integration and the development of portable and wearable medical displays. These advancements will further enhance medical imaging capabilities and create new possibilities for the use of displays in different healthcare settings.

Regional Insights

North America currently holds the largest share of the medical display market, driven by the region’s advanced healthcare infrastructure, high adoption of cutting-edge technologies, and substantial investment in healthcare IT. Europe follows closely, with a focus on improving healthcare systems and adopting new technologies in medical imaging.

The Asia-Pacific region is expected to witness the highest growth during the forecast period, fueled by the rapid expansion of healthcare facilities, increasing investment in medical technology, and the growing prevalence of chronic diseases. Countries like China, Japan, and India are at the forefront of this growth, with governments supporting advancements in healthcare infrastructure and digital health technologies.

Future Outlook

As the global healthcare sector continues to evolve, the demand for high-performance medical displays will only increase. The push for precision diagnostics, advancements in surgical techniques, and the growing reliance on digital health solutions will drive further innovation in the medical display market. With a projected CAGR of 5.1% over the forecast period from 2024 to 2031, the market is set to witness continuous growth, leading to enhanced healthcare delivery worldwide.

In conclusion, the global medical display market, valued at USD 2.2 billion in 2023, is expected to reach USD 3.27 billion by 2031. This growth reflects the increasing demand for high-quality medical imaging technologies, driven by advancements in healthcare services and a focus on improving diagnostic accuracy and treatment outcomes across the globe.

Other Trending Reports

Hospital Information System Market

Smart Hospitality Market

Biodegradable Medical Plastics Market

Clinical Microbiology Market

[heathcareforallworld]

Animal Tomography System Market Report 2032: A Comprehensive Study of Emerging Trends

Introduction

The Animal Tomography System Market is projected to witness significant growth by 2032, fueled by increasing demand for advanced diagnostic technologies in veterinary medicine, the growing prevalence of animal diseases, and rising investments in animal research. These systems are critical in providing detailed imaging of animals' internal structures, supporting accurate diagnosis and treatment. As animal health continues to gain importance in the medical and research communities, the animal tomography system market is poised for steady expansion.

Animal Tomography System Market Size was estimated at 6.95 (USD Billion) in 2023. The Animal Tomography System Market Industry is expected to grow from 7.84(USD Billion) in 2024 to 20.5 (USD Billion) by 2032. The Animal Tomography System Market CAGR (growth rate) is expected to be around 12.77% during the forecast period (2025 - 2032).

Market Overview

1. Rising Need for Advanced Veterinary Diagnostics

As pet ownership increases and the demand for high-quality veterinary care rises, the need for advanced diagnostic tools is becoming more pronounced. Animal tomography systems, including computed tomography (CT) and positron emission tomography (PET), provide non-invasive imaging that allows veterinarians to identify diseases and abnormalities that may not be detected through traditional methods.

In addition to improving diagnostic accuracy, these systems offer better monitoring of treatment progress and aid in surgical planning. The increasing focus on pet health, combined with the need for precision diagnostics in livestock management, is driving the growth of the Animal Tomography System Market.

2. Growth in Animal Research and Biotechnology

Animal research has seen significant growth over the past few years, particularly in areas such as genetics, disease modeling, and drug development. The use of advanced imaging systems like tomography has become essential for researchers to study disease progression, drug effects, and genetic traits in animals.

In the biotechnology sector, animal models are increasingly used to test the safety and efficacy of new drugs before they are approved for human use. These developments are spurring the demand for cutting-edge imaging systems that can provide detailed information about animal physiology and pathology. As a result, the market for animal tomography systems is expected to experience robust growth through 2032.

Key Market Trends

1. Technological Advancements in Imaging Systems

One of the key drivers of growth in the animal tomography system market is the continuous innovation in imaging technology. Manufacturers are focusing on enhancing the capabilities of tomography systems to offer higher resolution, faster imaging, and better portability.

Recent advancements in hybrid imaging technologies, such as PET-CT and PET-MRI, provide more comprehensive data by combining functional and anatomical imaging. These innovations allow for better disease characterization and earlier detection of abnormalities. As these systems become more affordable and accessible, their adoption in veterinary practices and research facilities is expected to rise, contributing to market growth.

2. Increasing Focus on Animal Health and Welfare

Globally, there has been a growing awareness of the importance of animal health and welfare, leading to increased spending on veterinary diagnostics and treatments. In many countries, pet owners are now more willing to invest in advanced diagnostic procedures to ensure the well-being of their pets.

Similarly, livestock health management is critical in ensuring food safety and preventing the spread of zoonotic diseases. The growing emphasis on improving the health and welfare of both companion animals and livestock is driving the demand for high-quality diagnostic tools, including tomography systems.

3. Emerging Markets and Expanding Veterinary Infrastructure

While North America and Europe have traditionally dominated the animal tomography system market, emerging markets in Asia-Pacific and Latin America are expected to provide new growth opportunities. These regions are experiencing rapid improvements in veterinary infrastructure and increasing investments in animal healthcare.

With rising disposable incomes, pet ownership is also on the rise in these regions, leading to increased demand for advanced veterinary services. Governments are recognizing the importance of improving animal health standards, which is further boosting the adoption of modern diagnostic tools such as tomography systems.

Market Opportunities

1. Growing Pet Insurance Coverage

One of the key opportunities driving the Animal Tomography System Market is the expanding pet insurance coverage in various countries. As more pet owners invest in insurance plans that cover advanced diagnostic procedures, the financial barriers to adopting tomography systems in veterinary clinics are being reduced.

This trend is encouraging veterinarians to invest in high-end imaging equipment, leading to increased market growth. With more pet insurance companies offering comprehensive coverage for diagnostic services, the demand for animal tomography systems is expected to rise significantly by 2032.

2. Increased Focus on Precision Medicine in Veterinary Care

Precision medicine, which tailors treatments to the specific needs of individual patients based on genetic, environmental, and lifestyle factors, is gaining traction in the veterinary field. Advanced imaging systems like tomography play a crucial role in supporting precision medicine by providing detailed insights into an animal’s health condition.

This shift toward personalized care is expected to drive the demand for sophisticated diagnostic tools in veterinary practices. As precision medicine becomes more prevalent, the need for accurate and detailed imaging will continue to grow, boosting the demand for animal tomography systems.

Conclusion

The Animal Tomography System Market is poised for substantial growth by 2032, driven by advancements in veterinary diagnostics, increased focus on animal health, and rising demand for animal research. Technological innovations in imaging systems, expanding veterinary infrastructure in emerging markets, and growing pet insurance coverage are key factors contributing to market growth.

As awareness of animal welfare continues to rise, and as more advanced diagnostic tools become available, the market for animal tomography systems is expected to expand significantly. This growth presents opportunities for manufacturers and healthcare providers to invest in innovative imaging technologies that can improve animal health outcomes and support cutting-edge research.

Other reports:

 Animals Cell Viability Assays market

 Anti-Ccp Fast Test Kit market

 Anti-Crp Antibody market

 Anti-Idiotype Antibody Production Service market

 Anti-Inos Antibody market

[tamanna31]

Future and Growth of Tissue Diagnostics Market by 2030

Tissue Diagnostics Market

The global tissue diagnostics market size was estimated at USD 5.19 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.15% from 2023 to 2030.

Tissue diagnostics remains a gold standard for cancer diagnosis as these technologies capture the anatomy of tumors. With rising incidences of cancer, the tissue diagnostics industry witnesses high demand with significant growth opportunities over the forecast period. The impact of COVID-19 on the tissue diagnostics industry has been significant. During the pandemic, there was a slowdown in routine medical procedures, including diagnostic testing, as healthcare resources were redirected toward managing the virus.

Gather more insights about the market drivers, restrains and growth of the Tissue Diagnostics Market

The pandemic led to a temporary decline in the demand for tissue diagnostics products and services. However, as the situation improved and healthcare systems adapted to the new normal, the market began to recover. The need for accurate diagnosis and monitoring of various diseases, including cancer, remained high, driving the demand for tissue diagnostics in the post-pandemic period.

Cancer incidences are increasing dramatically, which has caused a paradigm change in anatomic pathology. This, in turn, is contributing to the clinical pathology field's continued growth. Digitalization of diagnosis methods, increased use of liquid biopsy for cancer detection, and a continuous convergence of anatomical and molecular pathology. The importance of integrated bioinformatics and analyses increases as computational pathology gains momentum. Over the past two decades, the tissue diagnostics industry has changed as more advanced equipment has become available, making life easier for pathologists and physicians.

For instance, in May 2021, to increase the availability of precision medication for lung cancer, QIAGEN released its first FDA-approved tissue companion diagnostic to detect the KRAS G12C mutation in NSCLC tumors. The Rotor-Gene Q MDx instrument, a part of the modular QIAsymphony family of automation solutions, is used with the real-time qualitative PCR kit. This tool builds on QIAGEN's nine years of experience in researching and marketing KRAS CDx tests.

Globally, more than 14 million individuals are diagnosed with cancer each year, and by 2030, that figure is projected to increase to more than 21 million. Major market participants are introducing new cancer diagnosis products. For instance, Roche introduced its innovative BenchMark ULTRA PLUS system for cancer diagnostics in June 2022, enabling prompt, precise patient care. Pathologists can deliver high-quality, time-sensitive results to doctors and patients due to the BenchMark ULTRA PLUS tissue staining system's improved workflow, testing efficiency, and environmentally sustainable features.

Considering the rising worldwide cancer burden, various technologies, and improvements in tissue diagnostics (TDx) will increase pathology efficiency, which is essential for better cancer therapy and diagnosis. For example, Ibex Medical Analytics, the industry pioneer in AI-powered cancer diagnoses, and Alverno Laboratories announced a new deal in March 2023. It aims to expand the implementation of Ibex's Galen suite of Artificial Intelligence solutions to the entire Alverno network across Indiana and Illinois. The deployment comprises AI-powered solutions for cancer diagnosis across numerous tissue types and will help Alverno pathologists in providing the highest quality care for their patients.

A rise in the adoption rate of automated tissue-based diagnostic systems by research institutes enables them to diagnose tumors faster. In January 2023, MilliporeSigma announced its plans to expand its portfolio of antibodies for tissue diagnostics to help improve the classification of gliomas and other tumors in the nervous systems. Such R&D investments will ensure the market continues to grow.

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

The global hematologic malignancies market size was valued at USD 67.23 billion in 2023 and is projected to grow at a CAGR of 8.0% from 2024 to 2030.

The global precision diagnostics market size was estimated at USD 15.60 billion in 2023 and is projected to grow at a CAGR of 18.4% from 2024 to 2030.

Key Companies & Market Share Insights

The tissue diagnostics market is fragmented due to the presence of several medium-to-small and large participants in the marketspace. The advent of novel diagnostic models by key players to enhance their technology portfolio has raised competitiveness in the market. For instance, in June 2022, Roche announced the launch of VENTANA DP 600 - the next-generation slide scanner. This high-capacity slide scanner provides the pathology lab with workflow flexibility and ease of use while producing stained histology slides with exceptional image quality from tissue samples. Some prominent players in the global tissue diagnostics market include:

F. Hoffmann-La Roche Ltd.

Abbott Laboratories

Thermo Fisher Scientific Inc.

Siemens

Danaher

bioMérieux SA

QIAGEN

BD

Merck KGaA

GE Healthcare

BioGenex

Cell Signaling Technology, Inc.

Bio SB

DiaGenic ASA

Agilent Technologies

Order a free sample PDF of the Tissue Diagnostics Market Intelligence Study, published by Grand View Research.

[industrynewsupdates]

Tissue Diagnostics Market Business Growth, Opportunities and Forecast, 2030

The global tissue diagnostics market size was estimated at USD 5.19 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 7.15% from 2023 to 2030.

Tissue diagnostics remains a gold standard for cancer diagnosis as these technologies capture the anatomy of tumors. With rising incidences of cancer, the tissue diagnostics industry witnesses high demand with significant growth opportunities over the forecast period. The impact of COVID-19 on the tissue diagnostics industry has been significant. During the pandemic, there was a slowdown in routine medical procedures, including diagnostic testing, as healthcare resources were redirected toward managing the virus.

Gather more insights about the market drivers, restrains and growth of the Tissue Diagnostics Market

The pandemic led to a temporary decline in the demand for tissue diagnostics products and services. However, as the situation improved and healthcare systems adapted to the new normal, the market began to recover. The need for accurate diagnosis and monitoring of various diseases, including cancer, remained high, driving the demand for tissue diagnostics in the post-pandemic period.

Cancer incidences are increasing dramatically, which has caused a paradigm change in anatomic pathology. This, in turn, is contributing to the clinical pathology field's continued growth. Digitalization of diagnosis methods, increased use of liquid biopsy for cancer detection, and a continuous convergence of anatomical and molecular pathology. The importance of integrated bioinformatics and analyses increases as computational pathology gains momentum. Over the past two decades, the tissue diagnostics industry has changed as more advanced equipment has become available, making life easier for pathologists and physicians.

For instance, in May 2021, to increase the availability of precision medication for lung cancer, QIAGEN released its first FDA-approved tissue companion diagnostic to detect the KRAS G12C mutation in NSCLC tumors. The Rotor-Gene Q MDx instrument, a part of the modular QIAsymphony family of automation solutions, is used with the real-time qualitative PCR kit. This tool builds on QIAGEN's nine years of experience in researching and marketing KRAS CDx tests.

Globally, more than 14 million individuals are diagnosed with cancer each year, and by 2030, that figure is projected to increase to more than 21 million. Major market participants are introducing new cancer diagnosis products. For instance, Roche introduced its innovative BenchMark ULTRA PLUS system for cancer diagnostics in June 2022, enabling prompt, precise patient care. Pathologists can deliver high-quality, time-sensitive results to doctors and patients due to the BenchMark ULTRA PLUS tissue staining system's improved workflow, testing efficiency, and environmentally sustainable features.

Considering the rising worldwide cancer burden, various technologies, and improvements in tissue diagnostics (TDx) will increase pathology efficiency, which is essential for better cancer therapy and diagnosis. For example, Ibex Medical Analytics, the industry pioneer in AI-powered cancer diagnoses, and Alverno Laboratories announced a new deal in March 2023. It aims to expand the implementation of Ibex's Galen suite of Artificial Intelligence solutions to the entire Alverno network across Indiana and Illinois. The deployment comprises AI-powered solutions for cancer diagnosis across numerous tissue types and will help Alverno pathologists in providing the highest quality care for their patients.

A rise in the adoption rate of automated tissue-based diagnostic systems by research institutes enables them to diagnose tumors faster. In January 2023, MilliporeSigma announced its plans to expand its portfolio of antibodies for tissue diagnostics to help improve the classification of gliomas and other tumors in the nervous systems. Such R&D investments will ensure the market continues to grow.

Tissue Diagnostic Market Segmentation

Grand View Research has segmented the global tissue diagnostics market report based on technology, application, end-use, and region:

Technology Outlook (Revenue, USD Million, 2018 - 2030)

• Immunohistochemistry

o Instruments

o Slide Staining Systems

o Tissue Microarrays

o Tissue Processing Systems

o Slide Scanners

o Other Products

o Consumables

o Antibodies

o Reagents

o Kits

• In Situ Hybridization

o Instruments

o Consumables

o Software

• Primary & Special Staining

• Digital Pathology and Workflow

o Whole Slide Imaging

o Image Analysis Informatics

o Information Management System Storage & Communication

• Anatomic Pathology

o Instruments

o Microtomes & Cryostat Microtomes

o Tissue Processors

o Automatic Strainers

o Other Products

o Consumables

o Reagents & Antibodies

o Probes & Kits

o Others

Application Outlook (Revenue, USD Million, 2018 - 2030)

• Breast Cancer

• Non-small Cell Lung Cancer

• Prostate Cancer

• Gastric Cancer

• Other Cancers

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Research Laboratories

• Pharmaceutical Organizations

• Contract Research Organizations (CROs)

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

• Europe

o UK

o Germany

o Spain

o France

o Italy

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o South Korea

o Singapore

o Australia

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Browse through Grand View Research's Clinical Diagnostics Industry Research Reports.

• The global hematologic malignancies market size was valued at USD 67.23 billion in 2023 and is projected to grow at a CAGR of 8.0% from 2024 to 2030.

• The global precision diagnostics market size was estimated at USD 15.60 billion in 2023 and is projected to grow at a CAGR of 18.4% from 2024 to 2030.

Key Companies & Market Share Insights

The tissue diagnostics market is fragmented due to the presence of several medium-to-small and large participants in the marketspace. The advent of novel diagnostic models by key players to enhance their technology portfolio has raised competitiveness in the market. For instance, in June 2022, Roche announced the launch of VENTANA DP 600 - the next-generation slide scanner. This high-capacity slide scanner provides the pathology lab with workflow flexibility and ease of use while producing stained histology slides with exceptional image quality from tissue samples. Some prominent players in the global tissue diagnostics market include:

• F. Hoffmann-La Roche Ltd.

• Abbott Laboratories

• Thermo Fisher Scientific Inc.

• Siemens

• Danaher

• bioMérieux SA

• QIAGEN

• BD

• Merck KGaA

• GE Healthcare

• BioGenex

• Cell Signaling Technology, Inc.

• Bio SB

• DiaGenic ASA

• Agilent Technologies

Order a free sample PDF of the Tissue Diagnostics Market Intelligence Study, published by Grand View Research.

[wellnessweb]

Economic Factors Shaping Medical Imaging Market Size

The Medical Imaging Market size was valued at USD 39.7 billion in 2023 and is expected to reach USD 58.65 billion by 2031 with a growing CAGR of 5% over the forecast period of 2024-2031.The global medical imaging market is a dynamic landscape shaped by cutting-edge technology and evolving healthcare needs. Advancements in diagnostic modalities such as MRI, CT scans, ultrasound, and nuclear medicine have revolutionized medical diagnostics, offering precise insights into anatomical structures and pathological conditions.

This market's growth is propelled by increasing healthcare expenditure, rising prevalence of chronic diseases, and a growing aging population worldwide. Innovations in image resolution, software integration for enhanced analysis, and the advent of artificial intelligence for image interpretation are reshaping clinical practices, improving diagnostic accuracy, and facilitating personalized patient care. As medical imaging continues to evolve, driven by both technological innovation and expanding clinical applications, it promises to redefine the future of healthcare delivery, offering new avenues for early detection, treatment planning, and therapeutic monitoring.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/2989

Market Scope & Overview

The Medical Imaging Market  report offers in-depth details on significant end-users in addition to an estimate for the year in question. The market research offers an in-depth analysis of the main competitors in the industry, recent market developments, and significant trends influencing market development. The research report also discusses the crucial market elements like drivers, loopholes, restrictions, and other influencing factors.

Market researchers developed the forecasts, which are based on a thorough analysis of the regional distribution of the Medical Imaging Market . Both critical market-advancing and market-restraining factors are highlighted in the market research. Additionally provided are projections for market sales growth and annual revenue. These forecasts are crucial for determining the industry's long-term prospects.

Market Segmentation Analysis

By Product Type

CT Scanners

X Ray Imaging systems

MRI systems

Nuclear Imaging systems

Ultrasound Imaging systems

Others

By Application

Obstetrics and Gynaecology health

Orthopaedics

Cardiovascular and thoracic

General Imaging

Breast health

Others

COVID-19 Pandemic Impact Analysis

The COVID-19 pandemic and post-pandemic phase industry development trends, downstream consumer surveys, marketing channels, key distributors, significant customers, suppliers of necessary production equipment and raw materials, as well as downstream consumer surveys, marketing channels, and industry development trends are all examined in the Medical Imaging Market  research.

Regional Outlook

The market predictions and estimations consider how the market environment, as well as the political, social, and economic issues of the day, may affect different regions of the target market. Based on primary interviews, in-depth secondary research, and the opinions of internal subject matter experts, the research report's estimations and forecasts for the Medical Imaging Market .

Competitive Analysis

Current market trends like market expansion, mergers and acquisitions, and partnerships and collaborations are also taken into account in the Medical Imaging Market  analysis. Additionally provided during the market research are a thorough financial analysis, corporate strategy, SWOT analysis, a business overview, and details on recently announced goods and services.

Key Reasons to Purchase Medical Imaging Market  Report

A thorough analysis of the key regional markets, along with predictions for their future development with respect to the target market.

An in-depth market research report that includes present market trends and forecasts for the future to assist you in making an informed decision.

Key market insights that enables business owners to take advantage of opportunities across many geographies.

Conclusion

The Medical Imaging Market  research report offers guidance for creating strategies to overcome obstacles and take advantage of growth opportunities in the global market for both existing businesses and new ventures.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in re framing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Oncology Drugs Market Forecast

Osteoporosis Treatment Market Forecast

Peripheral Neuropathy MarketForecast

Active Pharmaceutical Ingredient MarketForecast

Blood Group Typing MarketForecast

[themarketupdate]

Global Metal Casing Market Will Hit Big Revenues In Future | Biggest Opportunity Of 2024

Latest added Global Metal Casing Market research study by Archive Market Research offers detailed outlook and elaborates market review till 2030. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are Amazon Web Services, Inc. (Washington, United States),Google LLC (California, United States),IBM Corporation (New York, United States),Microsoft Corporation (Washington, United States),SAP SE (Germany),Yellow Messenger (Karnataka, India),Labiba for Artificial Intelligence LLC (Dubai, United Arab Emirates),Gupshup (Maharashtra, India),SmartBots (Texas, United States),Aivo (Córdoba, Spain),Aifa.AI (Sydney, Australia),Dogtown Media. (California, United States),Peerbits. (Gujarat, India),Master of Code Global. (California, United States),Peltarion (Stockholm, Sweden),Verloop (Karnataka, India),Crisp IM SARL (France),LiveChat, Inc. (Massachusetts, United States),ManyChat, Inc. (San Francisco, United States),Chatfuel (San Francisco, United States),PandoraBots (California, United States),Botscrew (London, UK) etc.  Click for Free Sample Report + All Related Graphs & Charts https://archivemarketresearch.com/report/pet-snacks-and-treats-market-7/sample-report The Global Metal Casing Market size was valued at USD 33.27 billion in 2023 and is projected to reach USD 41.48 billion by 2032, exhibiting a CAGR of 3.2 % during the forecasts period. The latest edition of this report you will be entitled to receive additional chapter / commentary on latest scenario, economic slowdown and COVID-19 impact on overall industry. Further it will also provide qualitative information about when industry could come back on track and what possible measures industry players are taking to deal with current situation. Each of the segment analysis table for forecast period also high % impact on growth. The Global Global Metal Casing segments and Market Data Break Down are illuminated below: {"Component: Platform/Software Development Kit and Services","Deployment: Cloud and On-premises","Application: Website, Contact Centers, Social Media and Mobile Application","Industry: Banking, Financial Services and Insurance (BFSI"}

Have Any Questions Regarding Global Global Metal Casing Market Report, Ask Our Experts@ https://archivemarketresearch.com/report/pet-snacks-and-treats-market-7/enquiry-before-buy This report will give you an unmistakable perspective on every single reality of the market without a need to allude to some other research report or an information source. Our report will give all of you the realities about the past, present, and eventual fate of the concerned Market. Thanks for reading this article, we can also provide customized report as per company’s specific needs. You can also get separate chapter wise or region wise report versions including North America, Europe or Asia.

More Reports:

 https://archivemarketresearch.com/reports/global-metal-casing-market-1957  https://archivemarketresearch.com/reports/anatomic-pathology-market-3060 Contact US : Craig Francis (PR & Marketing Manager) Archive Market Research Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 sales@advancemarketanalytics.com

[bhavesh2022]

Europe Anatomic Pathology Market Trends, and Forecasts by 2028

The market research study titled “Europe Anatomic Pathology Market Share, Trends, and Outlook | 2028,” guides organizations on market economics by identifying current Europe Anatomic Pathology market size, total market share, and revenue potential. This further includes projections on future market size and share in the estimated period. The company needs to comprehend its clientele and the demand it creates to focus on a smaller selection of items. Through this chapter, market size assists businesses in estimating demand in specific marketplaces and comprehending projected patterns for the future.

The Europe Anatomic Pathology market report also provides in-depth insights into major industry players and their strategies because we understand how important it is to remain ahead of the curve. Companies may utilize the objective insights provided by this market research to identify their strengths and limitations. Companies that can capitalize on the fresh perspective gained from competition analysis are more likely to have an edge in moving forward.

With this comprehensive research roadmap, entrepreneurs and stakeholders can make informed decisions and venture into a successful business. This research further reveals strategies to help companies grow in the Europe Anatomic Pathology market.

Market Analysis and Forecast

This chapter evaluates several factors that impact on business. The economics of scale described based on market size, growth rate, and CAGR are coupled with future projections of the Europe Anatomic Pathology market. This chapter is further essential to analyze drivers of demand and restraints ahead of market participants. Understanding Europe Anatomic Pathology market trends helps companies to manage their products and position themselves in the market gap.

This section offers business environment analysis based on different models. Streamlining revenues and success is crucial for businesses to remain competitive in the Europe Anatomic Pathology market. Companies can revise their unique selling points and map the economic, environmental, and regulatory aspects.

Report Attributes

Details

Segmental Coverage

Product and Service

Instruments

Consumables

and Services

Application

Disease Diagnosis

Drug Discovery and Development

and Others

End User

Hospitals

Research Laboratories

Diagnostic Laboratories

and Others

Regional and Country Coverage

North America (US, Canada, Mexico)

Europe (UK, Germany, France, Russia, Italy, Rest of Europe)

Asia Pacific (China, India, Japan, Australia, Rest of APAC)

South / South & Central America (Brazil, Argentina, Rest of South/South & Central America)

Middle East & Africa (South Africa, Saudi Arabia, UAE, Rest of MEA)

Market Leaders and Key Company Profiles

F. HOFFMANN-LA ROCHE LTD.

Danaher

Hologic, Inc.

Agilent Technologies, Inc.

BioGenex

Diapath S.p.A.

Bio SB

MERCK KGaA

BD

PHC Holdings Corporation

Other key companies 

Our Unique Research Methods at Business Market Insights

We offer syndicated market research solutions and consultation services that provide complete coverage of global markets. This report includes a snapshot of global and regional insights. We pay attention to business growth and partner preferences, that why we offer customization on all our reports to meet individual scope and regional requirements.

Our team of researchers utilizes exhaustive primary research and secondary methods to gather precise and reliable information. Our analysts cross-verify facts to ensure validity. We are committed to offering actionable insights based on our vast research databases.

Strategic Recommendations

Strategic planning is crucial for business success. This section offers strategic recommendations needed for businesses and investors. Forward forward-focused vision of a business is what makes it through thick and thin. Knowing business environment factors helps companies in making strategic moves at the right time in the right direction.

Summary:

Europe Anatomic Pathology Market Forecast and Growth by Revenue | 2028

Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities

Market Segmentation – A detailed analysis by product, types, end-user, applications, segments, and geography

Competitive Landscape – Top key players and other prominent vendors

Author’s Bio: Bhavesh Shinde Senior Market Research Expert at Business Market Insights

[divyabodhwani23]

Enhancing Patient Outcomes: Innovations Driving Growth in the Vitrectomy Devices Market

The EMEA Vitrectomy Devices Market is a vital segment of the ophthalmic medical device industry, focusing on surgical instruments and equipment used for vitreoretinal procedures. Vitrectomy is a surgical procedure performed to treat various retinal conditions, including retinal detachment, macular hole, diabetic retinopathy, and vitreous hemorrhage. This market analysis explores the key drivers, trends, challenges, and opportunities shaping the EMEA Vitrectomy Devices Market.

𝐆𝐞𝐭 𝐟𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞: https://www.marketdigits.com/eMEA-vitrectomy-devices-market-1714054239

One of the primary drivers of the EMEA Vitrectomy Devices Market is the increasing prevalence of retinal diseases and age-related eye conditions across the region. Factors such as aging populations, lifestyle changes, and the rising incidence of diabetes contribute to the growing burden of retinal disorders, driving demand for vitrectomy procedures and associated devices. Vitrectomy devices, including vitreous cutters, illumination systems, and surgical probes, play a crucial role in facilitating safe and effective vitreoretinal surgeries, thereby addressing the unmet medical needs of patients with retinal pathologies.

The EMEA Vitrectomy Devices Market is valued at USD 612.2 million in 2024 and projected to reach USD 1,015.3 million by 2030, with a Compound Annual Growth Rate (CAGR) of 7.3% during the forecast period spanning 2024-2032.

Moreover, technological advancements in vitrectomy devices, such as the development of micro-incisional techniques, high-speed cutters, and wide-angle visualization systems, have enhanced surgical outcomes, reduced intraoperative complications, and shortened recovery times for patients undergoing vitreoretinal surgery. These innovations enable vitreoretinal surgeons to perform complex procedures with greater precision, dexterity, and control, leading to improved anatomical and functional outcomes for patients with retinal diseases.

Major vendors in the global EMEA Vitrectomy Devices market:  Aktive S.r.l., Alcon Inc., BVI, Bausch + Lomb, Carl Zeiss Meditec AG, Corza Medical, Hoya Surgical Optics, Johnson & Johnson Vision Care, Inc., NIDEK CO., LTD., OERTLI INSTRUMENTE AG, Topcon Corporation, and Others.

Furthermore, the increasing adoption of minimally invasive surgical techniques and vitrectomy instrumentation has revolutionized the field of vitreoretinal surgery, offering several advantages over traditional open surgeries, including smaller incisions, reduced tissue trauma, and faster visual rehabilitation. Minimally invasive vitrectomy procedures result in shorter hospital stays, less postoperative discomfort, and quicker return to daily activities for patients, contributing to the overall growth and acceptance of vitrectomy devices in clinical practice.

In addition to technological advancements, favorable reimbursement policies, regulatory initiatives, and healthcare infrastructure development support the growth of the EMEA Vitrectomy Devices Market. Reimbursement coverage for vitreoretinal surgeries and associated devices ensures patient access to essential healthcare services and facilitates the adoption of innovative surgical techniques and technologies by healthcare providers. Regulatory agencies, such as the European Medicines Agency (EMA) and national competent authorities, play a crucial role in ensuring the safety, efficacy, and quality of vitrectomy devices through rigorous evaluation and oversight.

However, the EMEA Vitrectomy Devices Market also faces challenges and barriers to growth, including pricing pressures, competitive dynamics, and the limited availability of skilled vitreoretinal surgeons in certain regions. The high cost of vitrectomy devices and associated consumables may pose affordability challenges for healthcare systems, particularly in resource-constrained settings or underfunded healthcare environments. Moreover, intense competition among market players and the presence of alternative treatment modalities, such as pharmacotherapy and laser therapy, may impact market penetration and product differentiation strategies in the EMEA region.

In conclusion, the EMEA Vitrectomy Devices Market presents significant growth opportunities driven by the increasing prevalence of retinal diseases, technological advancements in vitrectomy instrumentation, and favorable regulatory and reimbursement environments. Vitrectomy devices play a critical role in enabling vitreoretinal surgeons to perform safe, efficient, and minimally invasive procedures for patients with a wide range of retinal pathologies. By addressing unmet medical needs, driving innovation, and ensuring access to quality care, the EMEA Vitrectomy Devices Market contributes to the advancement of vitreoretinal surgery and the improvement of patient outcomes across the region.

[trendtrackershq]

Cone Beam Computed Tomography System Market: A Comprehensive Analysis of Growth Trends

The Cone Beam Computed Tomography System Market is on an upward trajectory, fueled by advancements in medical imaging technology and the increasing demand for precise diagnostic tools. According to a study by Next Move Strategy Consulting, the global CBCT System Market is predicted to reach USD 3.45 billion with a CAGR of 11.7% by 2030. This projection underscores the significant role CBCT systems are expected to play in various medical specialties, including dentistry, orthopedics, and otorhinolaryngology.

Request for a sample, here: https://www.nextmsc.com/cbct-systems-market/request-sample 

Analysis of Growth Trends:

Increasing Adoption in Dental Imaging:

The dental industry has been a major driver of growth in the CBCT System Market. Dentists are increasingly turning to CBCT systems for their ability to provide high-resolution 3D images of the oral and maxillofacial region. These images offer detailed insights into tooth and bone structures, facilitating accurate diagnosis and treatment planning for a wide range of dental procedures. From implant placement to root canal therapy and orthodontic treatment, CBCT imaging has become an indispensable tool in modern dentistry.

Furthermore, CBCT systems offer several advantages over traditional imaging modalities such as panoramic and periapical radiography. They provide volumetric data with isotropic resolution, allowing for precise measurements and multiplanar reconstructions. Additionally, CBCT scans require lower radiation doses compared to conventional CT scans, making them safer for patients. As a result, dental practices worldwide are integrating CBCT technology into their workflow to enhance diagnostic accuracy and improve patient outcomes.

Expanding Applications in Orthopedics and Otorhinolaryngology:

While CBCT systems have traditionally been associated with dental imaging, their applications extend beyond dentistry to other medical specialties. In orthopedics, CBCT imaging plays a crucial role in the evaluation of musculoskeletal conditions, preoperative planning, and intraoperative guidance. Orthopedic surgeons rely on CBCT scans to assess complex fractures, detect bone tumors, and plan for joint replacement surgeries. The ability to visualize bone anatomy in 3D helps surgeons accurately localize pathological lesions and determine optimal surgical approaches, leading to improved patient outcomes and reduced surgical complications.

Similarly, in otorhinolaryngology (ENT), CBCT imaging is used for the assessment of sinus disorders, temporal bone anatomy, and skull base pathology. CBCT scans provide detailed images of the paranasal sinuses, nasal cavity, and adjacent structures, aiding in the diagnosis and management of conditions such as sinusitis, nasal polyps, and skull base tumors. ENT specialists also rely on CBCT imaging for surgical planning, particularly in complex cases requiring endoscopic sinus surgery or skull base surgery. The availability of high-resolution CBCT images enhances the precision and safety of these procedures, leading to better postoperative outcomes and reduced risk of complications.

Technological Advancements Driving Market Growth:

Advancements in CBCT technology have played a pivotal role in driving market growth and expanding the clinical utility of CBCT systems. Manufacturers are continually innovating to improve image quality, reduce scan times, and enhance patient comfort and safety. One of the key areas of innovation is in image reconstruction algorithms, with the development of iterative reconstruction techniques that enable noise reduction and artifact suppression, resulting in clearer and more detailed images.

Another significant advancement is the integration of artificial intelligence (AI) algorithms into CBCT systems. AI-based image processing algorithms can automatically analyze CBCT images, identify anatomical structures, and detect pathological abnormalities with high accuracy. This automation streamlines the interpretation process, reduces the burden on radiologists, and ensures consistent and reliable diagnostic results. Moreover, AI algorithms can assist in radiation dose optimization by adjusting imaging parameters based on patient anatomy and clinical indication, thereby minimizing radiation exposure without compromising image quality.

Furthermore, manufacturers are investing in hardware innovations to improve the performance and functionality of CBCT systems. This includes the development of high-speed detectors, advanced X-ray tubes, and ergonomic design features to enhance user experience and workflow efficiency. Additionally, dual-energy imaging techniques are being introduced to differentiate between different tissue types based on their material composition, offering potential applications in tissue characterization and disease staging.

Inquire before buying, here: https://www.nextmsc.com/cbct-systems-market/inquire-before-buying

Growing Demand for Point-of-Care Imaging Solutions:

The shift towards point-of-care imaging solutions is another driving force behind the growth of the CBCT System Market. Healthcare providers are increasingly seeking compact, portable, and cost-effective imaging solutions that can be easily integrated into various clinical settings. CBCT systems are well-suited for point-of-care use due to their relatively small footprint, fast scan times, and intuitive user interfaces. These systems enable healthcare providers to perform on-site imaging procedures, obtain immediate diagnostic information, and make timely clinical decisions, thereby improving patient care and treatment outcomes.

Point-of-care CBCT imaging has numerous applications across different medical specialties and clinical scenarios. In dentistry, CBCT systems are commonly used in private dental clinics, academic institutions, and dental hospitals for routine diagnostic imaging, treatment planning, and intraoperative guidance. Orthopedic practices and sports medicine clinics utilize CBCT systems for on-site evaluation of sports-related injuries, fracture assessment, and preoperative planning of orthopedic surgeries. Similarly, emergency departments and urgent care centers deploy CBCT systems for rapid assessment of trauma patients, detection of internal injuries, and triage of critical cases.

The versatility and accessibility of point-of-care CBCT imaging make it an invaluable tool for healthcare providers seeking to optimize patient care delivery and enhance clinical decision-making at the point of care. By bringing advanced imaging capabilities closer to the patient, CBCT systems help reduce the need for referral to centralized imaging facilities, minimize treatment delays, and improve overall patient satisfaction and experience.

Rising Investments in Healthcare Infrastructure:

The increasing investments in healthcare infrastructure, particularly in emerging economies, are creating significant growth opportunities for the CBCT System Market. Governments and healthcare authorities are prioritizing the expansion and modernization of healthcare facilities to meet the growing demand for medical services and improve healthcare accessibility and affordability. As part of these initiatives, investments are being made in the procurement of advanced medical equipment, including CBCT systems, to equip healthcare facilities with state-of-the-art diagnostic capabilities.

Moreover, private healthcare providers are also investing in upgrading their imaging infrastructure to remain competitive and meet the evolving needs of patients. Dental clinics, hospitals, imaging centers, and specialty clinics are investing in CBCT systems to enhance their diagnostic capabilities, attract patients, and offer advanced treatment options. Additionally, technological advancements and economies of scale are driving down the cost of CBCT systems, making them more affordable and accessible to a wider range of healthcare providers, including small and medium-sized practices.

Furthermore, strategic partnerships and collaborations between industry players and healthcare stakeholders are facilitating technology transfer, knowledge exchange, and capacity building in emerging markets. Manufacturers are establishing distribution networks, training programs, and technical support services to ensure the successful adoption and utilization of CBCT systems in diverse healthcare settings. By investing in healthcare infrastructure and fostering collaboration, stakeholders are paving the way for the widespread adoption of CBCT technology and the realization of its potential to improve patient care and clinical outcomes globally.

Conclusion:

In conclusion, the Cone Beam Computed Tomography System Market is experiencing robust growth driven by factors such as increasing adoption in dental imaging, expanding applications in orthopedics and otorhinolaryngology, technological advancements, growing demand for point-of-care imaging solutions, and rising investments in healthcare infrastructure. As CBCT technology continues to evolve and innovate, it is poised to revolutionize medical imaging and reshape the landscape of diagnostic radiology. By addressing the unmet needs of healthcare providers and offering solutions that enhance diagnostic accuracy, treatment planning, and patient care delivery, CBCT systems are poised to play a pivotal role in shaping the future of healthcare.

[healthcaremarketfmi]

Anatomic Pathology Market Detailed Survey On Key Trends, Leading Players & Revolutionary Opportunities 2030

The global anatomic pathology market forecast is set to reach US$ 61.1 Mn in revenues by 2030, according to a new market study by ESOMAR-certified market research firm, Future Market Insights (FMI).

The anatomic pathology market is subject to integrating medical informatics standards to meet specific healthcare requirements by curtailing costs and improvising on efficiency.

Pathology laboratories are on the verge of refurbishment as new-fangled disease diagnostic models are making a beeline therein.

As of now, lymphoma, breast cancer, colorectal cancer, prostate cancer, cervical cancer, and lung cancer are a part of anatomic pathology.

Get Sample Report + Related Graphs & Charts @ https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

Key Takeaways

The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030

Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents

Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination

Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers

Key Participant Insights

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.

For instance ��

In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.

In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest’s infectious disease testing services.

In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

Expand operations in the future – To get requisite details, ask for a custom report@ https://www.futuremarketinsights.com/customization-available/rep-gb-12370

The other players in the veterinary imaging market include

Laboratory Corporation of America Holdings

Sakura Finetek USA, Inc.

F.Hoffmann-La Roche AG

Cardinal Health, Inc.

BioGenex

NeoGenomics

Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology market during the assessment period.

The Europe anatomic pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2030. The global anatomic pathology market is segmented in detail to cover every aspect and present a complete market intelligence approach to the reader.

The study provides compelling insights on anatomic pathology market on the basis of product & services type (Instruments (Microtomes & Cryostat, Tissue processors, Automatic Stainers, and Other products), consumables (Reagents & Antibodies, Probes & Kits, and Others), application (Disease Diagnosis, Drug Discovery and Development, and Others), and services (histopathology, cytopathology)) across seven geographies.